IRCT20231119060108N1招募中2 期
Safety and Efficacy of Rituximab in patients with juvenile dermatomyositis (JDM) who were admitted at Mofid children hospital
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 16 years(—)
- 性别
- All
入选标准
- •Patient under 16 years old
- •Patients with the diagnosis of dermatomyositis, which is confirmed based on the diagnosis criteria
排除标准
- •Presence of concomitant diseases and overlap syndrome
- •Contraindications for rituximab injection
研究者
相似试验
进行中(未招募)
不适用
Efficacy and safety of rituximab in patients with rheumatoid arthritis - FIRSTMedDRA version: 8.1Level: PTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2006-001000-37-DERoche Pharma AG300
进行中(未招募)
不适用
Efficacy of Rituximab treatment in patients with rheumatoid arthritis having inadequate response to TNF blockerTo investigate the efficacy of treatment with Rituximab (MabThera®) in patients with active RA whose current treatment with one or more TNF-blocker (Etanercept - Enbrel®, Infliximab – Remicade® or Adalimumab - Humira®) alone or in combination with MTX is insufficient measured by DAS28 activity index.EUCTR2006-004673-98-HURoche (Hungary) Ltd.20
已完成
不适用
Efficacy and safety of rituximab for patients with severe rheumatic diseaseChildhood-onset severe rheumatic disease (systemic lupus erhythematosus, dermatomyositis, poly myositis, systemic sclerosis , mixed connective tissue disease, Sjogren's syndrome, anti-phospholipid syndrome)JPRN-UMIN000018376Yokohama City University Hospital Department of Pediatrics20
已完成
2 期
The Evaluation of Efficacy and Safety of Rituximab (Genetical Recombination) in Refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients with Immunoglobulin G4 (IgG4) Autoantibodies in the Exploratory Clinical TrialChronic Inflammatory Demyelinating PolyneuropathyJPRN-UMIN000035753agoya University Hospital27
已完成
2 期
RECIPE TrialChronic Inflammatory Demyelinating PolyneuropathyJPRN-jRCT2041180037Iijima Masahiro25
